Table 2.
Analysis of the relationships among the expression of galectin-9 mRNA in liver cancer patients cancer-adjacent tissues and cancer tissues, and clinical characteristics
| Clinical characteristics | Cancer-adjacent tissues ΔCt values | Cancer tissues ΔCt values | T values | P values | |
|---|---|---|---|---|---|
| Sex | Male | 6.102 ± 0.021 | 7.321 ± 0.009 | 2.036 | > 0.05 |
| Female | 6.023 ± 0.011 | 7.120 ± 0.008 | |||
| Age | ≤ 65 | 5.951 ± 0.004 | 7.004 ± 0.012 | 2.114 | > 0.05 |
| > 65 | 6.123 ± 0.007 | 7.332 ± 0.008 | |||
| The size of tumor | < 3 cm | 6.104 ± 0.023 | 7.061 ± 0.031 | 2.051 | > 0.05 |
| 3-5 cm | 6.003 ± 0.011 | 6.985 ± 0.009 | |||
| > 5 cm | 5.905 ± 0.005 | 6.908 ± 0.014 | |||
| HBsAg | + | 6.231 ± 0.034 | 7.128 ± 0.044 | 2.230 | > 0.05 |
| - | 6.009 ± 0.021 | 6.995 ± 0.027 | |||
| Pathological differentiation | Well differentiated | 5.714 ± 0.035 | 7.338 ± 0.073 | 10.234 | < 0.05 |
| Moderately differentiated | 6.000 ± 0.033 | 7.206 ± 0.065 | |||
| Poorly differentiated | 6.230 ± 0.066 | 6.971 ± 0.074 | |||
| TNM | Level I | 6.039 ± 0.014 | 7.441 ± 0.010 | 10.921 | < 0.05 |
| Level II | 5.947 ± 0.054 | 7.360 ± 0.089 | |||
| Level IIII | 5.608 ± 0.037 | 7.021 ± 0.036 | |||
| Recurrence and metastasis | Yes | 6.332 ± 0.057 | 7.019 ± 0.047 | 9.107 | < 0.05 |
| No | 6.014 ± 0.007 | 6.872 ± 0.005 |